Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02266797
Other study ID # 13-00108
Secondary ID
Status Terminated
Phase Phase 3
First received
Last updated
Start date November 2013
Est. completion date September 1, 2015

Study information

Verified date September 2018
Source New York University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled study to examine the effect of local intravenous steroids following anterior cervical spine surgery on the development of dysphagia in patients.


Description:

The purpose of this randomized, double-blind, placebo-controlled study is to examine the effect of local intravenous steroids following anterior cervical spine surgery on the development of dysphagia in patients. This study aims to investigate if there is a difference in the efficacy of intravenous steroids compared to a placebo of physiological saline for patients undergoing anterior cervical spine surgery. Furthermore, this study aims to investigate the correlation between radiographic measurements of soft tissue swelling and the severity of dysphagia for patients. Finally, this study aims to examine the impact of intravenous steroids on nausea and radicular pain in patients. Secondary outcome measures will include patient focused outcomes questionnaires, pain medication requirements, and fusion rates.


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date September 1, 2015
Est. primary completion date September 1, 2015
Accepts healthy volunteers No
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria:

- The subjects included in the study are patients undergoing an anterior cervical spine procedure.

Exclusion Criteria:

- Patients with greater than ASA grade II will be excluded. Patients with non-degenerative conditions, such as trauma, tumors, infection, radiation, and diabetes will be excluded. Patients with posterior procedures will be excluded. Patients with clinical pre-operative dysphagia, indicated by a score of 3 or higher on the EAT-10 questionnaire,19 will also be excluded. Patients who are pregnant will be excluded from this study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexamethasone
The first dose will be given before the incision and the subsequent doses will be given 8 and 16 hours after the first dose. Dexamethasone doses will be 0.3 mg/kg for the first dose and 0.15 mg/kg for each subsequent dose.
Other:
Saline
The first dose will be given before the incision and the subsequent doses will be given 8 and 16 hours after the first dose.

Locations

Country Name City State
United States Center for Musculoskeletal Care (CMC) New York New York
United States NYU Langone Medical Center New York New York
United States NY Spine Institute Westbury New York

Sponsors (1)

Lead Sponsor Collaborator
New York University School of Medicine

Country where clinical trial is conducted

United States, 

References & Publications (5)

Bazaz R, Lee MJ, Yoo JU. Incidence of dysphagia after anterior cervical spine surgery: a prospective study. Spine (Phila Pa 1976). 2002 Nov 15;27(22):2453-8. — View Citation

Leonard R, Belafsky P. Dysphagia following cervical spine surgery with anterior instrumentation: evidence from fluoroscopic swallow studies. Spine (Phila Pa 1976). 2011 Dec 1;36(25):2217-23. doi: 10.1097/BRS.0b013e318205a1a7. — View Citation

Martin RE, Neary MA, Diamant NE. Dysphagia following anterior cervical spine surgery. Dysphagia. 1997 Winter;12(1):2-8; discussion 9-10. — View Citation

Stewart M, Johnston RA, Stewart I, Wilson JA. Swallowing performance following anterior cervical spine surgery. Br J Neurosurg. 1995;9(5):605-9. — View Citation

Winslow CP, Winslow TJ, Wax MK. Dysphonia and dysphagia following the anterior approach to the cervical spine. Arch Otolaryngol Head Neck Surg. 2001 Jan;127(1):51-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Intravenous Corticosteroids Effect on Post-operative Dysphagia The severity of dysphagia will be evaluated by dysphagia questionnaires and a two week postoperative swallow evaluation by a licensed swallowing expert. If recommended by the swallow evaluation, a videofluoroscopic swallow study (VFSS) will be performed to further evaluate the severity of dysphagia. 12 months
Primary The Correlation Between Radiographic Data and the Extent of Dysphagia in Patients. Soft-tissue swelling will be measured by the anterior cervical soft-tissue shadow width on lateral cervical radiographs. The extent of dysphagia will be evaluated by the dysphagia questionnaires, the swallow evaluation, and the VFSS, if necessary. 12 months
Secondary The Efficacy of Intravenous Steroids on Aspiration Rates of Patients Undergoing Anterior Cervical Spine Surgery. Aspiration rates will be evaluated by the percentage of patients in each group with post-operative aspiration. 12 months
Secondary Examine the Impact of Dexamethasone on the Development of Postoperative Nausea. This will be quantified by the visual analogue scale (VAS) questionnaire for nausea and measuring the number of vomiting episodes following surgery. Immediate post-operatively
Secondary Examine the Impact of Dexamethasone on Radicular Pain. This will be quantified by the NDI questionnaire and VAS questionnaire for neck pain and arm pain. 12 months
Secondary Examine Whether Intravenous Steroids Affect the Outcomes of Surgery, for Example, Fusion Rates. The outcomes of surgery will be examined through the 1 year post-operative appointment. 12 months